Letter to the Editor: indirect treatment comparison of anifrolumab efficacy versus belimumab in adults with systemic lupus erythematosus

por Ballew, Nick, Mian, Aneela, Levy, Roger Abramino, Bradley, Matt
Publicado 2022

Belimumab versus anifrolumab in adults with systemic lupus erythematosus: an indirect comparison of clinical response at 52 weeks

por Neupane, Binod, Shukla, Pragya, Slim, Mahmoud, Martin, Amber, Petri, Michelle, Bertsias, George K, Kim, Alfred H J, Fanouriakis, Antonis, Levy, Roger A, Chauhan, Deven, Ballew, Nick
Publicado 2023